ADVERTISEMENT

Alkem Labs Q1 Results Review - Margin Gains Offset Revenue Shortfall: Nirmal Bang

Consistent growth and limited capex requirements would help the company drive high free cashflow generation of ~Rs 17.7 billion/Rs 22.2 billion in FY25E/FY26E, says the brokerage.

<div class="paragraphs"><p>Medicines. (Source: Milivigerova/ pexels)</p></div>
Medicines. (Source: Milivigerova/ pexels)
NDTV Profit’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer NDTV Profit’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.
To continue reading this story
Subscribe to unlock & enjoy all Members-only benefits

Choose a plan

Renews automatically. Cancel anytime.
Still Not convinced ? Know More